5Upchurch GR Jr,Welch GN, Fabian A J, et al. Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol chem. 1997,272(27) :17012.
6Stamler JS. Osborne JA ,Jaraki O,et al. Adverse vascular effect of ho-mocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest, 1993,91 ( 1 ) :308.
7Eikelboom JW, Hankey GJ,Anand SS,et al. Association between high homocysteine anti ischemic stroke due to large-and small-after?" disease but not other etiological subtypes of ischemic stroke. Stroke,2000,31(5) :1 069.
8Sacco RL,Roberts JK,Jacobs BS. Homocystein as a risk factor for ischemic stroke:an epidemiologieal story in evolution. Neuroepidemiology, 1998, 17 (4):167.
9Ueland PM ,Refsum H ,Stabler SP,et al. Total homocystein in plasma or serum: methods and clinical application. Clin Chem,1993.39(9):1 764.
二级参考文献12
1Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total concentration and risk of stroke in middle-aged British men. Lancet, 1995,346: 1396
2Eikeboom JW, Hankey GJ, Anad SS, et al. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke, 2000,31:1069
3Lalouschek W, Aull S, Serles W, et al. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and healthy control subjects. J Lab Clin Med, 1999,133: 575
4Brattstrom L, Lindgren A, Israelsson B, et al. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Int Med, 1994,236: 633
5Malinow MR, Nieto FJ, Szklo M, et al. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation, 1993,87:1107
6Verhoef P, Hennekens CH, Malinow R, et al. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke, 1994,25:1924
7Brattstrom L, Lindgren A, Israelsson B, et al. Hyperhomocysteinemia: in stroke prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur Clin Invest, 1992,22: 214
8Stehouwer CD, Weijenberg MP, Vanden BM, et al. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb Vasc Biol, 1998,18:1895
9Kittner SJ, Giles WH, Macko RF, et al. Homocysteine and risk of cerebral infarction in a biracial population : the stroke prevention in young woman study. Stroke, 1999,30: 1554
10Yoo JH, Chung CS, Kang SS. Relation of plasma homocysteine levels to cerebral infarction and cerebral atherosclerosis. Stroke, 1998,29: 2478
4Lathrop Stern L, Shane B, Bagley PJ, et al. Combined marginal folate and riboflavin status affect homocysteine methylation in cultured immortalized lymphocytes from persons homozygous for the MTHFR C677T mutation [ J ]. J Nutr,2003,133(9) : 2716.
5Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [ J ]. Nat Genet, 1995, 10(1) :111.
6Modonna P, de Stefano V, Coppola A, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with history of ischemic stroke [ J ]. Stroke, 2002,33(1) :51.
7Alluri RV, Mohan V, Komandur S, et al. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study [ J ]. Eur J Neurol, 2005,12 ( 1 ) :40.
